PubRank

A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 26086184)

Published in Alzheimers Dement on June 15, 2015

Authors

Kristel Sleegers1, Karolien Bettens2, Arne De Roeck2, Caroline Van Cauwenberghe2, Elise Cuyvers2, Jan Verheijen2, Hanne Struyfs3, Jasper Van Dongen2, Steven Vermeulen2, Sebastiaan Engelborghs4, Mathieu Vandenbulcke5, Rik Vandenberghe6, Peter Paul De Deyn7, Christine Van Broeckhoven8, BELNEU consortium

Author Affiliations

1: Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. Electronic address: kristel.sleegers@molgen.vib-ua.be.
2: Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
3: Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
4: Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp Middelheim and Hoge Beuken, Antwerp, Belgium.
5: Department of Old Age Psychiatry and Memory Clinic, University of Leuven and University Hospitals Leuven Gasthuisberg, Leuven, Belgium.
6: Laboratory for Cognitive Neurology, Department of Neurology, University of Leuven and University Hospitals Leuven Gasthuisberg, Leuven, Belgium.
7: Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp Middelheim and Hoge Beuken, Antwerp, Belgium; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
8: Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. Electronic address: christine.vanbroeckhoven@molgen.vib-ua.be.

Articles citing this ↘

The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med (2015) 1.09

Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease. J Alzheimers Dis (2016) 0.81

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement (2015) 0.81

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathol (2017) 0.79

Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease. J Alzheimers Dis (2016) 0.78

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid. J Alzheimers Dis (2016) 0.75

Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults. Neurobiol Aging (2016) 0.75

Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front Neurol (2017) 0.75

Genetic Influences on the Development of Fibrosis in Crohn's Disease. Front Med (Lausanne) (2016) 0.75

Polygenic risk scores in familial Alzheimer disease. Neurology (2017) 0.75

Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort. Alzheimers Dement (Amst) (2016) 0.75

Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer's disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) project. BMJ Open (2017) 0.75

Genetic variation at 16q24.2 is associated with small vessel stroke. Ann Neurol (2017) 0.75

Articles by these authors ⇆

Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study. Lancet Neurol (2015) 1.67

Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging (2013) 1.30

Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiol Aging (2013) 0.95

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Neurobiol Aging (2015) 0.84

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Mol Oncol (2015) 0.79

Validation of the semi-quantitative static SUVR method for [(18)F]-AV45 PET by pharmacokinetic modeling with an arterial input function. J Nucl Med (2017) 0.76